RenatoMariaSantosMD

PubMed

• 16 citations
  Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention.
  Robert J. Applegate, Matthew T. Sacrinty, Pascha Schafer, Justin W. Smith, Sanjay Gandhi, Michael A. Kutcher, Renato M. Santos, Adam C. Cecile, William C. Little> ;Catheterization and Cardiovascular Interventions. 2013 Oct 1
• 20 citations
  Transitioning to the radial artery as the preferred access site for cardiac catheterization: An academic medical center experience†
  Samuel J. Turner, Matthew T. Sacrinty, Michael R. Manogue, William C. Little, Sanjay Gandhi, Michael A. Kutcher, Renato M. Santos, Robert J. Applegate> ;Catheterization and Cardiovascular Interventions. 2012 Aug 1
• Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice.
  Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ> ;Circ Cardiovasc Qual Outcomes. 2011-07-01
• 4 citations
  Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes.
  Kevin R Hayes, Robert J. Applegate, Matthew T. Sacrinty, Michael A. Kutcher, Sanjay Gandhi, Renato M. Santos, William C. Little> ;The Journal of Invasive Cardiology. 2010 Jun 1
• Prognostic implications of vascular complications following PCI.
  Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R> ;Catheter Cardiovasc Interv. 2009-07-01
• Chronic Kidney Disease and Dipstick Proteinuria Are Risk Factors for Stent Thrombosis in Patients with Myocardial Infarction
  Kurt R Daniel, Nathan D Lambert, Renato M Santos, Samuel J Turner, Michael A Kutcher, Robert J Applegate, David C Sane> ;American Heart Journal. 2009 Apr
• 3-year comparison of drug-eluting versus bare-metal stents.
  Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC> ;JACC Cardiovasc Interv. 2009-03-01
• Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes.
  Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC> ;Circ Cardiovasc Interv. 2009-02-01
• Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007.
  Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC> ;JACC Cardiovasc Interv. 2008-06-01
• 11 citations
  Culprit vessel PCI versus traditional cath and PCI for STEMI.
  Robert J. Applegate, Stacy H. Graham, Sanjay Gandhi, Michael A. Kutcher, Matthew T. Sacrinty, Renato M. Santos, William C. Little> ;The Journal of Invasive Cardiology. 2008 May 1
• 19 citations
  Vascular complications in women after catheterization and percutaneous coronary intervention 1998-2005.
  Robert J. Applegate, Matthew T. Sacrinty, Michael A. Kutcher, Talal T. Baki, Sanjay Gandhi, Frederic R. Kahl, Renato M. Santos, William C. Little> ;The Journal of Invasive Cardiology. 2007 Sep 1
• 9 citations
  Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention using thrombin hemostatic patch-fac...
  Robert J. Applegate, Matthew T. Sacrinty, Michael A. Kutcher, Talal T. Baki, Sanjay Gandhi, Renato M. Santos, Frederic R. Kahl, William C. Little> ;The Journal of Invasive Cardiology. 2007 Apr 1
• 21 citations
  Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy.
  Jason T. Call, Matthew T. Sacrinty, Robert J. Applegate, William C. Little, Renato M. Santos, Talal T. Baki, Sanjay Gandhi, Frederic R. Kahl, Michael A. Kutcher> ;The Journal of Invasive Cardiology. 2006 Oct 1
• Vascular complications with newer generations of angioseal vascular closure devices.
  Applegate RJ, Sacrinty M, Kutcher MA, Gandhi SK, Baki TT, Santos RM, Little WC> ;J Interv Cardiol. 2006-02-01
• 1 citations
  Local administration of L-703,081 using a composite polymeric stent reduces platelet deposition in canine coronary arteries
  Renato M. Santos, Jean Francois Tanguay, James J. Crowley, Kevin R. Kruse, Debbie Sanders-Millare, James P. Zidar, Harry R. Phillips, Yahye Merhi, Elias Garcia-Cantu, ...> ;The American Journal of Cardiology. 1998 Sep 1
• Join now to see all

Journal Articles

• Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention  
  Applegate RJ, Sacrinty MT, Schafer PE, Smith JW, Gandhi SK, Kutcher MA, Santos RM, Cecile AC, Little WC, Cathet Cardiovasc Interv, 1/1/2013
• Transitioning to the radial artery as the preferred access site for cardiac catheterization: An academic medical center experience  
  Turner S, Sacrinty M, Monogue M, Little W, Gandhi S, Kutcher M, Santos R, ApplegateR, Catheter Cardiovasc Interv, 1/1/2012
• Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice  
  Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ, Circ Cardiovasc Qual Outcomes, 1/1/2011
• Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes  
  Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC, J Invasive Cardiol, 1/1/2010
• Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction  
  Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC, Am Heart J, 1/1/2009
• Prognostic implications of vascular complications following PCI  
  Applegate RJ, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Cath Cardiovasc Intervent, 1/1/2009
• 3-year comparison of drug-eluting stents versus bare metal stents  
  Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, J Am Coll Cardiol Intv, 1/1/2009
• Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes  
  Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, Circ Cardiovasc Interv, 1/1/2009
• Incidence of coronary stent thrombosis based on academic research consortium definitions  
  Applegate RJ, Sacrinty MT, Little WC, Santos RM, Gandhi SK, Kutcher MA, Am J Cardiol, 1/1/2008
• Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: propensity score analysis  
  Applegate RJ, Sacrinty M, Kutcher M, Santos R, Gandhi S, Little W, Catheter Cardiovasc Interv, 1/1/2008
• Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007  
  Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC, J Am Coll Cardiol Intv, 1/1/2008
• "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents  
  Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC, J Am Coll Cardiol, 1/1/2008
• Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction  
  Miller CD, Roe MT, Mulgund J, Hoekstra JW, Santos R, Pollack CV Jr, Ohman EM, Gibler WB, Peterson ED, Am J Med, 1/1/2007
• Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial  
  Miller CD, Banerjee A, Mahaffey KW, Kontos MC, Fermann G, Pollack CV Jr, Antman E, Aylward P, Goodman SG, Santos R, Ferguson JJ, Califf RM, Hoekstra JW, Eur Heart J, 1/1/2007
• Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)  
  Echols MR, Mahaffey KW, Banerjee A, Pieper KS, Stebbins A, Lansky A, Cohen MG, Velazquez E, Santos R, Newby LK, Gurfinkel EP, Biasucci L, Ferguson JJ, Califf RM, Am J Cardiol, 1/1/2007
• Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death  
  Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC, Am J Cardiol, 1/1/2007
• Vascular complications with newer generations of Angioseal vascular closure devices  
  Applegate RJ, Sacrinty M, Kutcher MA, Gandhi SK, Baki TT, Santos RM, Little WC, J Interv Cardiol, 1/1/2006
• Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003  
  Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC, Catheter Cardiovasc Interv, 1/1/2006
• Renal artery stenting: characteristics and outcomes after 363 procedures  
  Lederman RJ, Mendelsohn FO, Santos RM, Phillips HR, Stack RS, Crowley JJ, Am Heart J, 1/1/2001
• Local drug delivery of argatroban from a polymeric-metallic composite stent reduces platelet deposition in a swine coronary model  
  Kruse KR, Crowley JJ, Tanguay JF, Santos RM, Millare DS, Phillips HR, Zidar JP, Stack RS, Catheter Cardiovasc Interv, 1/1/1999
• Kissing stents in the aortic bifurcation  
  Mendelsohn FO, Santos RM, Crowley JJ, Lederman RJ, Cobb FR, Phillips HR, Weissman NJ, Stack RS, Am Heart J, 1/1/1998
• Progression of renal artery stenosis in patients undergoing cardiac catheterization  
  Crowley JJ, Santos RM, Peter RH, Puma JA, Schwab SJ, Phillips HR, Stack RS, Conlon PJ, Am Heart J, 1/1/1998
• Join now to see all

Books/Book Chapters

• Goldman's Cecil medicine 
  Chapter: Vascular disorders of the kidney 
  Page 783 - 788Dubose TD Jr, Santos RMEditors: Goldman L, Schafer AI.Elsevier/Saunders, Philadelphia, PAEdition 24th,2012
• Cecil medicine 
  Chapter: Vascular disorders of the kidney 
  Page 891 - 897DuBose TD Jr, Santos RMEditors: Goldman L, Ausiello D.Saunders Elsevier, Philadelphia, PAEdition 23rd,2008

Abstracts/Posters

• Influence of stent type on 30-day percutaneous coronary intervention readmissions.
  Applegate RJ, Sacrinty MT, Green DR, Gandhi SK, Kutcher MA, Santos RM, Zhao DX, Cathet Cardiovasc Interv, 1/1/2014
• Cost effectiveness of Everolimus-eluting compared to propensity score matched bare metal stenting: an analysis of a selected stent strategy.
  Applegate RJ, Sacrinty M, Gandhi S, Kutcher M, Santos R, Little W, J Am Coll Cardiol, 1/1/2013
• Gender differences in vascular complications associated with transfemoral and transradial cardiac catheterization and PCI: a single-center experience.
  Anderson J, Sacrinty M, Turner S, Gandhi S, Santos R, Kutcher M, Little W, Applegate R, J Am Coll Cardiol, 1/1/2013
• Peak troponin I greater than 5 times the 99th percentile after PCI does not define a high-risk group.
  Butler M, Sacrinty M, Little W, Applegate R, Kutcher M, Santos R, Gandhi S, J Am Coll Cardiol, 1/16/2012
• Cost effectiveness of Everolimus-eluting stents compared to first generation drug-eluting stents in contemporary clinical practice.
  Applegate R, Sacrinty M, Gandhi S, Kutcher M, Santos R, Smith T, Little W, J Am Coll Cardiol, 1/1/2012
• Contrast use and acute kidney injury in contemporary clinical practice.
  Applegate R, Sacrinty M, Allem J, Gandhi S, Kutcher M, Santos R, Smith T, Little W, J Am Coll Cardiol, 1/1/2012
• Cost effectiveness of everolimus-eluting stents compared to propensity score matched bare metal stents in contemporary clinical practice.
  Applegate RJ, Sacrinty MT, Gandhi SK, Kutcher MA, Santos RM, Smith TD, Little WC, J Am Coll Cardiol, 1/1/2012
• Cost-effectiveness analysis of propensity matched radial and femoral cardiac catheterization and coronary intervention.
  Schafer P, Sacrinty MT, Smith JW, Little W, Gandhi S, Kutcher M, Santos R, Smith T, Cecile AC, Applegate R, J Am Coll Cardiol, 1/1/2012
• Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention.
  Applegate R, Sacrinty M, Schafer P, Smith J, Gandhi S, Kutcher M, Santos R, Cecile A, Little W, Catheter Cardiovasc Interv, 1/1/2012
• Resource utilization for propensity matched radial and femoral catheterization and intervention.
  Schafer PE, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Cecile AC, Applegate RJ, J Am Coll cardiol, 1/1/2011
• Cath Lab Utilization during Transition to the Radial Artery as Preferred Access: The Wake Forest Academic Medical Center Experience.
  Turner S, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Manogue, MR, Applegate RJ, J Am Coll Cardiol, 1/1/2011
• Bleeding avoidance strategy: Transition from femoral to radial artery as the preferred access for cardiac procedures. The Wake Forest Academic Medical Center experience.
  Manogue MR, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Turner SJ, Applegate RJ, J Am Coll Cardiol, 1/1/2011
• Cost effectiveness of drug-eluting stents versus bare metal stents in clinical practice: Effect of stent length and diameter.
  Schafer P, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, Applegate RJ, J Am Coll Cardiol, 1/1/2011
• Bleeding avoidance strategy: transition from femoral to radial artery as the preferred access for cardiac procedures. The Wake Forest academic medical center experience.
  Applegate RJ, Kutcher, MA, Little WC, Gandhi SK, Turner, SJ, Sacrinty, MT, Santos RM, J Am Coll Cardiol, 1/1/2011
• Cost-effectiveness of "off-label" drug-eluting stent versus bare metal stent use.
  Schafer P, Sacrinty M, Kutcher MA, Santos R, Gandhi SK, Little WC, Applegate RJ, J Am Coll Cardiol, 1/1/2010
• Prognostic implications of vascular complications following PCI.
  Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R, Catheter Cardiovasc Interv, 1/1/2009
• Drug-eluting stent versus bare metal stent use in patients with chronic kidney disease.
  Santos RM, Sacrinty MT, Kutcher MA, Gandhi SK, Little WC, Applegate RJ, J Am Coll Cardiol, 1/1/2009
• Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.
  Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC, J Am Coll Cardiol, 1/1/2009
• Clinical outcomes of bare metal stents versus drug-eluting stents target vessel revascularization: evidence for a high-risk bare metal stent cohort.
  Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC, J Am Coll Cardiol, 1/1/2009
• Three-year comparison of drug-eluting versus bare metal stents.
  Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, J Am Coll Cardiol, 1/1/2009
• Prognostic implications of post percutaneous coronary intervention vascular complications.
  Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC, Am J Cardiol, 1/1/2008
• Culprit vessel primary percutaneous coronary intervention for ST elevation myocardial infarction shorter door to balloon time.
  Graham SH, Applegate RJ, Gandhi SK, Sacrinty MT, Baki TT, Santos RM, Little WC, Kutcher MA, J Am Coll Cardiol, 1/1/2008
• Drug-eluting stents for ST elevation myocardial infarction: evidence for benefit at two years.
  Gandhi SK, Kay JD, Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Little WC, J Am Coll Cardiol, 1/1/2008
• Drug-eluting stents versus bare metal stents in saphenous vein grafts at 2 years.
  Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC, J Am Coll Cardiol, 1/1/2008
• Off-label DES vs. BMS treatment: Outcomes at 2 years.
  Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Baki TT, Gandhi SK, Little WC, Am J Cardiol, 1/1/2007
• Join now to see all

Lectures

• Top Ten Dieting Tips 
  Joslin Diabetes Center, Winston Salem, NC - 1/29/2014
• ACS, 2012 Update 
  Winston-Salem, NC - 1/27/2014
• The New Cathlab: Advanced Cardiac Procedures 
  Winston-Salem, NC - 1/13/2014
• Introduction to the Cardiac Catheterization Lab and Coronary Anatomy 
  Winston-Salem, NC, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2015 - 1/1/2014
• Coronary Physiology 
  Winston-Salem, NC, 2009, 2010, 2011, 2012, 2013, 2015 - 1/1/2014
• Peripheral Vascular Disease Overview 
  Winston-Salem, NC, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2015 - 1/1/2014
• Renal Artery Denervation 
  Asheville, NC - 1/10/2013
• Health Fair 
  Clemmons United Methodist Church, Clemmons, NC - 1/9/2013
• Refractory HTN and Renal Denervation 
  Winston-Salem, NC - 1/6/2013
• Acute Coronary Syndromes 
  Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC - 1/5/2013
• Renal Artery Stenosis 
  Winston-Salem, NC - 1/1/2013
• Novel Antiplatelet and Anticoagulant Agents 
  Wilkes Regional Medical Center, North Wilkesboro, NC - 1/20/2012
• Chest Pain in Primary Care 
  Winston-Salem, NC - 1/17/2012
• Chronic Stable Angina 
  Winston-Salem, NC - 1/15/2012
• Hypertensive Emergencies 
  Winston-Salem, NC - 1/26/2011
• The Thoracic Aorta for the General Internist 
  Winston-Salem, NC - 1/8/2011
• Lowering Cholesterol the Natural Way 
  Winston-Salem, NC - 1/15/2010
• Lowering Cholesterol 
  Winston-Salem, NC - 1/2/2008
• Metabolic Syndrome and Cardiovascular Risk 
  Village Inn and Conference Center, Clemmons, NC - 1/2/2007
• Review of Drug Eluting Stents 
  Winston-Salem, NC - 1/22/2006
• Clinico-Path Conference 
  Winston-Salem, NC - 1/1/2006
• Management of Peripheral Vascular Disease 
  Mt. Airy, NC - 1/27/2005
• Treatment and Prevention of Coronary Artery Disease 
  Multiple Locations, 2005 - 1/25/2005
• Lipid Management Post MI 
  Charlotte, NC - 1/25/2005
• Clinical Research in the Practice Setting 
  1/23/2005
• Join now to see all